11 – 20 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women.
(
- Contribution to journal › Article
-
Mark
The Women's Health in the Lund Area (WHILA) study-An overview.
(
- Contribution to journal › Article
- 2009
-
Mark
Nonhormonal drug use and its relation to androgens in perimenopausal women: a population-based study of Swedish women. The Women's Health in the Lund Area Study.
(
- Contribution to journal › Article
-
Mark
Prevalence of symptoms in relation to androgen concentrations in women using estrogen plus progestogen and women using estrogen alone.
(
- Contribution to journal › Article
-
Mark
Vasomotor symptoms are associated with a lower bone mineral density.
(
- Contribution to journal › Article
-
Mark
Exposure to p,p'-DDE: a risk factor for type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
The relation between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women's Health in the Lund Area (WHILA) study.
(
- Contribution to journal › Article
- 2008
-
Mark
Symptoms in peri- and postmenopausal women in relation to testosterone concentrations: data from The Women's Health in the Lund Area (WHILA) study
(
- Contribution to journal › Article
-
Mark
Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study.
(
- Contribution to journal › Article
- 2007
-
Mark
One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
(
- Contribution to journal › Article